Augmedix Announces Participation in Winter Wonderland Best Ideas Investor Conference
Augmedix (Nasdaq: AUGX) announced participation in the Third Annual Winter Wonderland Best Ideas Conference from February 21-24, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Augmedix (Nasdaq: AUGX) announced participation in the Third Annual Winter Wonderland Best Ideas Conference from February 21-24, 2023. CEO Manny Krakaris will engage in a live fireside chat on February 21 at 1:00 p.m. ET with analyst Brooks O’Neil. The session aims to highlight Augmedix's innovative ambient medical documentation solutions that reduce clinician burnout and enhance patient care. Interested investors can attend one-on-one meetings throughout the conference. For more details on the webcast, visit this link.
Positive
- Participation in a notable investment conference, increasing visibility among investors.
- Opportunity for direct engagement between management and investors through one-on-one meetings.
Negative
- None.
Details
News Market Reaction – AUGX
The recorded move for AUGX in the trading session of this news was +4.12%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that management will attend the Third Annual Winter Wonderland Best Ideas Conference taking place virtually on February 21 - 24, 2023.
Manny Krakaris, Chief Executive Officer, will participate in a live fireside chat with Lake Street Capital Markets research analyst Brooks O’Neil at 1:00 p.m. ET on Tuesday, February 21, 2023. Management will also conduct one-on-one investor meetings throughout the conference.
Details for the livestream of the fireside chat and webcast replay are below.
| Date: | Tuesday, February 21 | |
| Time: | 1:00 p.m. ET | |
| Webcast: | https://www.webcaster4.com/Webcast/Page/2952/47633 |
Attending investors interested in meeting with Augmedix management during the conference can contact the IR team at investors@augmedix.com. Investors can also register for the conference here.
About Augmedix
Augmedix, Inc. (Nasdaq: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners.
Augmedix is on a mission to help clinicians and patients form a human connection at the point of care without the intrusion of technology. Augmedix’s products extract data from natural physician-patient conversations and convert it to medical notes in real time, which are seamlessly transferred to the EHR. To achieve this, the company’s Ambient Automation Platform uses Automated Speech Recognition and Natural Language Processing, supported by medical documentation specialists.
Leveraging this platform, Augmedix’s products relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in leveraging point-of-care data by making connections between millions of physician-patient interactions and analyzing them to deliver actionable insights that elevate patient care.
Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit augmedix.com.
Contact Information
Investors:
Matt Chesler, CFA
FNK IR
(646) 809-2183
augx@fnkir.com
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.